News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MIM Corporation And Chronimed (CHMD) Shareholders Approve Merger; BioScrip To Be One Of Largest Specialty Pharmacies In US


10/19/2005 5:12:58 PM

ELMSFORD, N.Y. & MINNEAPOLIS--(BUSINESS WIRE)--March 9, 2005--MIM Corporation (NASDAQ:MIMS) and Chronimed Inc. (NASDAQ:CHMD) today announced that MIM and Chronimed obtained the requisite approvals for the merger of MIM and Chronimed at special shareholder meetings held earlier today. The holders of Chronimed common stock will receive 1.12 shares of MIM Corporation common stock in the merger. Upon consummation of the merger, MIM and Chronimed become one company and will change its name to BioScrip, Inc. The combined company will trade on Nasdaq National Market under the symbol "BIOS".

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES